So-Young Revenue Surges 46% but Losses Widen; Rating Downgraded to Hold

What happened

So-Young's 1Q2026 revenue surged 46% YoY driven by its pivot to offline aesthetic clinics. However, net losses widened year-on-year as contributions from high-margin online operations fell and expansion costs rose. The company's rapid clinic expansion from 19 centers in Dec 2024 to 39 by Sep 2025 has yet to translate into consolidated profitability. Meanwhile, the legacy online marketplace continues to weaken, with purchasing users and paying service providers declining. With cash reserves declining and a permanent CFO still not appointed, the risk profile has increased, justifying a rating downgrade.

Implication

Investors should note that while revenue growth is impressive, it is overshadowed by deteriorating margins and rising costs. The loss of high-margin online revenue and increased spending on clinic expansion means profitability remains elusive. The company's cash position is declining, and the absence of a permanent CFO raises governance concerns. The clinic model has shown improving unit economics, but this has not yet flowed through to the corporate bottom line. Until SY can show narrowing losses and stabilization of cash, the stock is likely to remain under pressure, with a potential downside to $2.00 in a bear scenario.

Thesis delta

The earlier thesis that clinic growth would drive a profit inflection is now challenged by continued margin deterioration. The latest data shows that while revenue accelerates, losses widen, indicating that operating leverage is not materializing. This validates the cautious WAIT stance and suggests that the path to profitability is longer and more uncertain than previously assumed.